In baseball, preparing for the first pitch requires a great deal of practice and builds on a spectacular amount of behind-the-scenes effort. Being a scientist is not much different - amazing discoveries, treatments, and technologies resulting from countless hours of energy and effort. That’s where Dr. A.J. Mellott saw an opportunity to make a difference with Ronawk, LLC, a biotech startup company that’s developing an innovative technology to help researchers produce stem cells at a massive scale. This technology allows scientists to do more experiments, test new ideas, and devote their time to something that could be translated to patient impact.
Checkout out the lest updates from Ronawk for the month of November.
As we are just labeled as one of the KC Top VC-Backed companies in 2020, we are excited to announce that we are competing to be one the Coolest Things Made in Kansas!
We are excited to announce that we are listed as Startland News Kansas City's Top VC-Backed Companies.
As COVID-19 continues to wage war on the world, researchers in an Olathe-based lab are generating trillions of human cells that could be used to cure the ever-lingering virus.
T-Blocks are changing the way primary stem cells are grown. The technology, owned by the Kansas City-based startup, Ronawk LLC and co-founders A.J. Mellott and Heather Decker, is conducting extensive research on stem cells at the University of Kansas Medical Center.
Ronawk is here to support the drive to rapidly develop effective diagnostic tools, therapies, and vaccines against COVID-19.
Dr. Mellott and Ronawk are accepted into the Class of 2020 Pipeline Fellows.
Ronawk LLC is honored to have won Cellink’s first Shark Tank Competition this year at the Partnership Conference in New Orleans!
Ronawk, LLC was recognized by the KC Biz Journal during their successful Q4 '19 Trade Show bringing large publicity behind their 3D T-Block cell technology.